Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy

BACKGROUND: The necessity for adjuvant chemotherapy (ACT) in locally advanced rectal cancer (LARC) patients who achieve pathological complete response (pCR) after pre-operative chemoradiotherapy (CRT) is still not identified. We aimed to investigate the therapeutic value of ACT in these patients. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jian-Hong, Lin, Jun-Zhong, Rong, Yu-Ming, Zhu, Ying, Deng, Yu-Xiang, Zhao, Yu-Jie, Lu, Zhen-Hai, Wu, Xiao-Jun, Pan, Zhi-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101492/
https://www.ncbi.nlm.nih.gov/pubmed/30151204
http://dx.doi.org/10.1093/gastro/goy009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101492/
https://www.ncbi.nlm.nih.gov/pubmed/30151204
http://dx.doi.org/10.1093/gastro/goy009

Ejemplares similares